A Benefit–Risk Assessment of the Use of Proton Pump Inhibitors in the Elderly

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Drugs & Aging

• Publication date

  2014-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40266-014-0166-4PMID 24634248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Textbook of Pharmacoepidemiology

  2021cited by this paper
• Clostridium difficile infection.

  2015cited by this paper
• Overuse of proton pump inhibitors.

  2015cited by this paper
• Bone density in proton pump inhibitors users: a prospective study

  2013influential reference
• Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care

  2013cited by this paper
• Risk Factors for Falls with Use of Acid-Suppressive Drugs

  2013cited by this paper
• Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals.

  2013cited by this paper
• Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals.

  2013influential reference
• Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.

  2013cited by this paper
• Low‐dose acetylsalicylic acid and gastrointestinal ulcers or bleeding – a cohort study of the effects of proton pump inhibitor use patterns

  2013cited by this paper
• Canadian Association of Gastroenterology position statement: hip fracture and proton pump inhibitor therapy-a 2013 update.

  2013cited by this paper
• Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis

  2013cited by this paper
• Short- and long-term mortality in males and females with fragility hip fracture in Norway. A population-based study

  2013cited by this paper
• Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care

  2013cited by this paper
• No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.

  2013cited by this paper
• Continuous decline in incidence of hip fracture: nationwide statistics from Finland between 1970 and 2010

  2013cited by this paper
• Cyclo‐oxygenase‐2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?

  2013cited by this paper
• Serum magnesium and proton-pump inhibitors use: a cross-sectional study.

  2013cited by this paper
• Potentially Inappropriate Prescribing in Older People with Dementia in Care Homes

  2012cited by this paper
• Chronic Proton Pump Inihibitor Therapy and Calcium Metabolism

  2012cited by this paper
• Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report

  2012cited by this paper
• Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis

  2012cited by this paper
• Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland.

  2012cited by this paper
• A comparison of the acid‐inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism

  2012cited by this paper
• Glad you brought it up: a patient-centred programme to reduce proton-pump inhibitor prescribing in general medical practice.

  2012cited by this paper
• Inappropriate Prescribing of Proton Pump Inhibitors in Older Patients

  2012cited by this paper
• Inappropriate prescribing of proton pump inhibitors in older patients: effects of an educational strategy.

  2012cited by this paper
• Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis

  2012influential reference
• Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal ‐ a 617 400‐patient study

  2012cited by this paper
• Blinded randomised controlled study of the effect of a discharge communication template on proton pump inhibitor prescribing.

  2012cited by this paper
• Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy.

  2012cited by this paper
• Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

  2011cited by this paper
• Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases

  2011cited by this paper
• Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies

  2011cited by this paper
• Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors

  2011cited by this paper
• Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly.

  2011cited by this paper
• Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors

  2011cited by this paper
• The persistent exclusion of older patients from ongoing clinical trials regarding heart failure.

  2011cited by this paper
• Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly.

  2011cited by this paper
• Meta-analysis: risk of fractures with acid-suppressing medication.

  2011cited by this paper
• Cytochrome 2 C 19 * 17 Allelic Variant , Platelet Aggregation , Bleeding Events , and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement

  2011cited by this paper
• Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study

  2011cited by this paper
• Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents

  2010cited by this paper
• A case series of proton pump inhibitor-induced hypomagnesemia.

  2010cited by this paper
• PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Appropriateness of treatment recommendations for PPI in hospital discharge letters

  2010cited by this paper
• Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes

  2010cited by this paper
• Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement

  2010cited by this paper
• International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding

  2010cited by this paper
• Use of proton pump inhibitors and mortality among institutionalized older people.

  2010cited by this paper
• Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.

  2010cited by this paper
• Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype.

  2010influential reference
• Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss.

  2010cited by this paper
• Cardiovascular and Smooth Muscle Pharmacology in the Next Decade

  2010cited by this paper
• Overuse of Acid Suppression Therapy in Hospitalized Patients

  2010cited by this paper
• A comparison of the acid‐inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism

  2010cited by this paper
• Drug-induced acute interstitial nephritis

  2010cited by this paper
• Chocolate consumption and effects on serotonin synthesis.

  2010cited by this paper
• Meta‐analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel

  2010cited by this paper
• Patients' willingness to discuss trade-offs to lower their out-of-pocket drug costs.

  2010cited by this paper
• Infectious diarrhea

  2010cited by this paper
• Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.

  2010cited by this paper
• Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.

  2009cited by this paper
• Conditions and drugs interfering with thyroxine absorption.

  2009cited by this paper
• The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease

  2009cited by this paper
• Hypomagnesemia induced by several proton-pump inhibitors.

  2009cited by this paper
• Guidelines for Prevention of NSAID-Related Ulcer Complications

  2009influential reference
• Proton Pump Inhibitors and Bone Fractures?

  2009cited by this paper
• Do Proton Pump Inhibitors Attenuate the Effect of Aspirin on Platelet Aggregation? A Randomized Crossover Study

  2009cited by this paper
• Hypomagnesaemia due to use of proton pump inhibitors--a review.

  2009cited by this paper
• ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

  2008influential reference
• Update of nutrient-deficiency anemia in elderly patients.

  2008cited by this paper
• Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians.

  2008cited by this paper
• Prevalence of anaemia in older persons: systematic review

  2008cited by this paper
• Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults

  2008cited by this paper
• Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia

  2008cited by this paper
• Mortality following hip fracture: trends and geographical variations over the last 40 years.

  2008cited by this paper
• Do acid-lowering agents affect vitamin B12 status in older adults?

  2008cited by this paper
• Use of proton pump inhibitors and risk of osteoporosis-related fractures

  2008cited by this paper
• Clostridium difficile infection.

  2008cited by this paper
• Increase in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole

  2008cited by this paper
• Omeprazole and refractory hypomagnesaemia

  2008cited by this paper
• The Effect of Famotidine, Esomeprazole, and Ezetimibe on Levothyroxine Absorption

  2008cited by this paper
• Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases

  2007cited by this paper
• Drug interactions between proton pump inhibitors and antiretroviral drugs

  2007cited by this paper
• Systematic review: proton pump inhibitor‐associated acute interstitial nephritis

  2007cited by this paper
• Use of acid-suppressing drugs and the risk of bacterial gastroenteritis.

  2007cited by this paper
• Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism.

  2007cited by this paper
• Low-dose aspirin and upper gastrointestinal damage:epidemiology, prevention and treatment

  2007cited by this paper
• Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression

  2007cited by this paper
• Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients.

  2007cited by this paper
• Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis

  2007cited by this paper
• Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.

  2007cited by this paper
• Proton pump inhibitors and acute interstitial nephritis: Report and analysis of 15 cases

  2006cited by this paper
• Proton Pump Inhibitors, Histamine H2 Receptor Antagonists, and Other Antacid Medications and the Risk of Fracture

  2006cited by this paper
• Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study

  2006cited by this paper
• Long-term proton pump inhibitor therapy and risk of hip fracture.

  2006cited by this paper
• Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

  2006cited by this paper
• Persistence and adherence to proton pump inhibitors in daily clinical practice

  2006influential reference
• Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis.

  2006cited by this paper
• Proton-pump inhibitors and hypomagnesemic hypoparathyroidism.

  2006cited by this paper

• Proton pump inhibitors and risk of fracture in older adults: a systematic review and meta-analysis.

  2025cites this paper
• Helicobacter pylori Eradication Treatment in Older Patients

  2024cites this paper
• The silent epidemic: Inappropriate use of proton pump inhibitors among hospitalized patients.

  2024cites this paper
• The Aging Stomach: Clinical Implications of H. pylori Infection in Older Adults—Challenges and Strategies for Improved Management

  2024cites this paper
• Proton pump inhibitors and cardiovascular risk: a critical review

  2024cites this paper
• Associated Factors to Efficacy and Tolerance of Immunotherapy in Older Patients with Cancer Aged 70 Years and Over: Impact of Coprescriptions

  2023cites this paper
• Asociación entre los niveles de vitamina B12 y el deterioro cognitivo en personas mayores

  2023cites this paper
• Proton pump inhibitors

  2023cites this paper
• Magnitude and Determinants of Long-term Use of Proton Pump Inhibitors Among Portuguese Older Adults in Primary Health Care.

  2023cites this paper
• Questionable Safety of Proton Pump Inhibitor Use in Children.

  2023cites this paper
• Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study

  2023cites this paper
• Nutrition policy: developing scientific recommendations for food-based dietary guidelines for older adults living independently in Ireland

  2022cites this paper
• JianpiQinghua granule reduced PPI dosage in patients with nonerosive reflux disease: A multicenter, randomized, double-blind, double-dummy, noninferiority study.

  2021cites this paper
• Multiple Micronutrients, Including Zinc, Selenium and Iron, Are Positively Associated with Anemia in New Zealand Aged Care Residents

  2021cites this paper
• Factors associated with the use of gastrointestinal medicines amoung older people with intellectual disabilities in Ireland

  2020cites this paper
• Acute kidney injury following the use of different proton pump inhibitor regimens: A real‐world analysis of post‐marketing surveillance data

  2020cites this paper
• Medication-related factors associated with proton pump inhibitor prescription beyond official guidelines in older adults

  2020cites this paper
• Attitudes towards use of proton pump inhibitors among geriatricians in Italy

  2019cites this paper
• Predictors of Inappropriate Proton Pump Inhibitors Use in Elderly Patients

  2019cites this paper
• The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study

  2018cites this paper
• The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis

  2018cites this paper
• Evaluation of Prescribing Appropriateness and Initiatives to Improve Prescribing of Proton Pump Inhibitors at Vancouver General Hospital.

  2018cites this paper
• Costs of medication in older patients: before and after comprehensive geriatric assessment

  2018cites this paper
• Proton pump inhibitor use and risk of hip fractures among community‐dwelling persons with Alzheimer's disease—a nested case‐control study

  2018cites this paper
• We have had a gutful: The need for deprescribing proton pump inhibitors

  2018cites this paper
• Impact of proton pump inhibitors on renal function and structure; new concepts

  2017cites this paper
• Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults

  2017cites this paper
• Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer’s disease

  2017cites this paper
• Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

  2017cites this paper
• From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis

  2017cites this paper
• Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer’s disease

  2017cites this paper
• Prevalence and predictors of non‐evidence based proton pump inhibitor use among elderly nursing home residents in the US

  2017cites this paper
• Assessment of vitamin B12 tissue stores in elderly proton pump inhibitor users

  2017cites this paper
• Potential risks associated with some commonly used drugs among older people in institutional settings - focus on proton pump inhibitors and drugs with anticholinergic properties

  2017influential citation
• Déprescrire les inhibiteurs de la pompe à protons: Lignes directrices de pratique clinique fondées sur les données probantes.

  2017cites this paper
• Strategies to Foster Appropriate Proton Pump Inhibitor Use

  2017influential citation
• Use of proton pump inhibitors and mortality after hip fracture in a nationwide study

  2017cites this paper
• Update on Medication Use in Older Adults

  2016cites this paper
• Functional Dyspepsia.

  2016cites this paper
• Effects of Non-Steroidal Anti-Inflammatory Drugs on the Gastrointestinal and Cardiovascular System

  2016cites this paper
• Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care.

  2016cites this paper
• Prevalence of Medication-Related Risks for Falls and Osteoporosis at a Hospital Network: A Post-hoc Analysis

  2016cites this paper
• Causes, Consequences and Public Health Implications of Low B-Vitamin Status in Ageing

  2016cites this paper
• Assessment of Urinary Methylmalonic Acid Levels in Older Adults on Proton Pump Inhibitors

  2015cites this paper
• A tool for prediction of risk of rehospitalisation and mortality in the hospitalised elderly: secondary analysis of clinical trial data

  2015cites this paper
• PRO‐OSTEO Extend I study (improving osteoporosis management in the acute and rehabilitation settings): multicentre audit

  2015cites this paper
• The aged gut in inflammatory bowel diseases.

  2015cites this paper
• Proton pump inhibitor-induced Sweet’s syndrome: report of acute febrile neutrophilic dermatosis in a woman with recurrent breast cancer

  2015cites this paper
• Medications That Older Adults in Hospice Care in the United States Take, 2007

  2015cites this paper
• Multimorbidities and Overprescription of Proton Pump Inhibitors in Older Patients

  2015cites this paper
• Inhibiteurs de la pompe à proton chez les sujets âgés, évaluation des pratiques professionnelles en médecine générale

  2014cites this paper
• arriba »PPI absetzen« Modul-Beschreibung

  year unknowncites this paper